Structure via PubChem · Public domain (PubChem)
famprofazone
Sign in to saveFamprofazone (Gewodin, Gewolen) is a nonsteroidal anti-inflammatory agent (NSAID) of the pyrazolone series which is available over-the-counter in some countries such as Taiwan. It has analgesic, anti-inflammatory, and antipyretic effects. Famprofazone has been known to produce methamphetamine as an active metabolite, with 15–20% of an oral dose being converted to it. As a result, famprofazone has occasionally been implicated in causing positives on drug tests for amphetamines.
In the Vinony graph
Within Vinony's link graph, famprofazone is referenced by 1,808 other articles, and connects out to N-methyl-1-(3,4-methylenedioxyphenyl)-2-butanamine, 2C-G and D-methamphetamine.
It sits within the topics Amines, Chemical pages without DrugBank identifier and Designer prodrugs.
Its subject is documented across 7 Wikipedia language editions.
Chemical data
- Formula
- C24H31N3O
- Molecular weight
- 377.5 g/mol
- IUPAC name
- 1-methyl-5-[[methyl(1-phenylpropan-2-yl)amino]methyl]-2-phenyl-4-propan-2-ylpyrazol-3-one
- SMILES
- CC(C)C1=C(N(N(C1=O)C2=CC=CC=C2)C)CN(C)C(C)CC3=CC=CC=C3
- InChIKey
- GNUXVOXXWGNPIV-UHFFFAOYSA-N
- XLogP
- 5
- Polar surface area
- 26.8 Ų
- H-bond donors
- 0
- H-bond acceptors
- 3
- Formal charge
- 0
via PubChem
Drug data · ChEMBL
- Max clinical phase
- Phase 2
- Molecule type
- Small molecule
via ChEMBL · EBI
Wikidata facts
- Subclass of
- chemical compound
- Mass
- 377.247
Show 2 more facts
- chemical formula
- C₂₄H₃₁N₃O
- canonical SMILES
- CC(C)C1=C(N(N(C1=O)C2=CC=CC=C2)C)CN(C)C(C)CC3=CC=CC=C3
Sources (2)
via Wikidata · CC0
~1 min read
Encyclopedic overview
2 sectionsContents
- See also
- References
{{Drugbox | IUPAC_name = 1-methyl-5-{[methyl(1-phenylpropan-2-yl)amino]methyl}-2-phenyl-4-(propan-2-yl)-1,2-dihydro-3H-pyrazol-3-one | image = Famprofazone.png | image_class = skin-invert-image
| tradename = | pregnancy_category = | legal_status = Rx-only | routes_of_administration = Oral
Excerpted from Wikipedia’s “famprofazone” article, available under the CC BY-SA 4.0 licence.